Diebold Nixdorf, Incorporated
DBD · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,116 | $2,061 | $1,644 | $1,618 |
| - Cash | $263 | $295 | $307 | $296 |
| + Debt | $934 | $1,063 | $1,055 | $1,047 |
| Enterprise Value | $2,787 | $2,829 | $2,393 | $2,369 |
| Revenue | $945 | $915 | $841 | $989 |
| % Growth | 3.3% | 8.8% | -14.9% | – |
| Gross Profit | $248 | $234 | $202 | $236 |
| % Margin | 26.2% | 25.6% | 24.1% | 23.9% |
| EBITDA | $105 | $70 | $48 | $132 |
| % Margin | 11.1% | 7.7% | 5.7% | 13.4% |
| Net Income | $41 | $12 | -$8 | $6 |
| % Margin | 4.3% | 1.3% | -1% | 0.6% |
| EPS Diluted | 1.09 | 0.33 | -0.22 | 0.15 |
| % Growth | 230.3% | 250% | -246.7% | – |
| Operating Cash Flow | $37 | $30 | $16 | $196 |
| Capital Expenditures | -$13 | -$17 | -$10 | -$10 |
| Free Cash Flow | $25 | $13 | $6 | $186 |